A new type of mesenchymal stem cells (MSCs) that expresses stage-specific embryonic antigen 3 (SSEA-3) and the mesenchymal cell marker CD105 are known as multilineage-differentiating stress-enduring (Muse) cells. Studies have shown that stem cells in suspension cultures are more likely to generate embryoid body–like stem cell spheres and maintain an undifferentiated phenotype and pluripotency. We separated Muse cells derived from human dermal fibroblasts by long-term trypsin incubation (LTT) through suspension cultures in methylcellulose. The Muse cells obtained expressed several pluripotency markers, including Nanog, Oct4, Sox2, and SSEA-3, and could differentiate in vitro into cells of the three germ layers, such as hepatocytes (endodermal), neural cells (ectodermal) and adipocytes, and osteocytes (mesodermal cells). These cells showed a low level of DNA methylation and a high nucleo-cytoplasmic ratio. Our study provides an innovative and exciting platform for exploring the potential cell-based therapy of various human diseases using Muse cells as well as their great possibility for regenerative medicine.
Get full access to this article
View all access options for this article.
References
1.
ByrneJ.A., NguyenH.N., Reijo, and PeraR.A. (2009). Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One, 4, e7118.
2.
ChenJ., and PeiD. (2012). Reprogramming in suspension. Nat. Methods, 9, 449–451.
3.
ChenV.C., and CoutureL.A. (2015). The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks. Methods Mol. Biol., 1283, 13–21.
4.
ChoK.A., LimG.W., JooS.Y., WooS.Y., SeohJ.Y., ChoS.J., HanH.S., and RyuK.H. (2011). Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Liver Int. 31, 932–939.
5.
ChoiH., LeeR.H., BazhanovN., OhJ.Y., and ProckopD.J. (2011). Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood, 118, 330-338.
6.
DezawaM. (2011). Tissue repairing cells that exist among mesenchymal stem cells; their potential for cell-based therapy. Nihon Rinsho, 69, 2128–2135.
7.
FluriD.A., TongeP.D., SongH., BaptistaR.P., ShakibaN., ShuklaS., ClarkeG., NagyA., and ZandstraP.W. (2012). Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat. Methods, 9, 509–516.
8.
GriffinM.D., EllimanS.J., CahillE., EnglishK., CeredigR., and RitterT. (2013). Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: How well are we joining the dots?. Stem Cells, 31, 2033–2041.
9.
HanJ.W., and YoonY.S. (2012). Epigenetic landscape of pluripotent stem cells. Antioxid. Redox Signal., 17, 205–223.
10.
HaraguchiY., MatsuuraK., ShimizuT., YamatoM., and OkanoT. (2015). Simple suspension culture system of human iPS cells maintaining their pluripotency for cardiac cell sheet engineering. J. Tissue Eng. Regen. Med., 9, 1363–1375.
11.
HeneidiS., SimermanA.A., KellerE., SinghP., LiX., DumesicD.A., and ChazenbalkG. (2013). Awakened by cellular stress: Isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PLoS One, 8, e64752.
12.
HongH.S., LeeJ., LeeE., KwonY.S., LeeE., AhnW., JiangM.H., KimJ.C., and SonY. (2009). A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat. Med., 15, 425–435.
13.
KarS., ParbinS., DebM., ShilpiA., SenguptaD., RathS.K., RakshitM., PatraA., and PatraS.K. (2014). Epigenetic choreography of stem cells: The DNA demethylation episode of development. Cell. Mol. Life Sci., 71, 1017–1032.
KurodaY., KitadaM., WakaoS., NishikawaK., TanimuraY., MakinoshimaH., GodaM., AkashiH., InutsukaA., NiwaA., and ShigemotoT. (2010). Unique multipotent cells in adult human mesenchymal cell populations. Proc. Natl. Acad. Sci. USA, 107, 8639–8643.
16.
KurodaY., KitadaM., WakaoS., and DezawaM. (2011). Bone marrow mesenchymal cells: How do they contribute to tissue repair and are they really stem cells? Arch. Immunol. Ther. Exp. (Warsz.), 59, 369–378.
17.
KurodaY., WakaoS., KitadaM., MurakamiT., NojimaM., and DezawaM. (2013). Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat. Protoc., 8, 1391–1415.
18.
LiuJ., YangZ., QiuM., LuoY., PangM., WuY., and ZhangY. (2013). Developmental potential of cloned goat embryos from an SSEA-3(+) subpopulation of skin fibroblasts. Cell. Reprogram., 15, 159–165.
19.
LuH.E., TsaiM.S., YangY.C., YuanC.C., WangT.H., LinX.Z., TsengC.P., and HwangS.M. (2011). Selection of alkaline phosphatase-positive induced pluripotent stem cells from human amniotic fluid-derived cells by feeder-free system. Exp. Cell Res., 317, 1895–1903.
20.
OguraF., WakaoS., KurodaY., TsuchiyamaK., BagheriM., HeneidiS., ChazenbalkG., AibaS., and DezawaM. (2014). Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine. Stem Cells Dev. 23, 717–728.
21.
QiuJ., TakagiY., HaradaJ., TopalkaraK., WangY., SimsJ.R., ZhengG., HuangP., LingY., ScaddenD.T., and MoskowitzM.A. (2009). p27Kip1 constrains proliferation of neural progenitor cells in adult brain under homeostatic and ischemic conditions. Stem Cells, 27, 920–927.
22.
SimermanA.A., DumesicD.A., and ChazenbalkG.D. (2014). Pluripotent muse cells derived from human adipose tissue: A new perspective on regenerative medicine and cell therapy. Clin. Transl. Med., 3, 12.
23.
TamaiK., YamazakiT., ChinoT., IshiiM., OtsuruS., KikuchiY., IinumaS., SagaK., NimuraK., ShimboT., and UmegakiN. (2011). PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc. Natl. Acad. Sci. USA, 108, 6609–6614.
24.
WakaoS., KitadaM., KurodaY., ShigemotoT., MatsuseD., AkashiH., TanimuraY., TsuchiyamaK., KikuchiT., GodaM., and NakahataT. (2011). Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc. Natl. Acad. Sci. USA, 108, 9875–9880.
25.
WakaoS., KitadaM., KurodaY., and DezawaM. (2012a). Isolation of adult human pluripotent stem cells from mesenchymal cell populations and their application to liver damages. Methods Mol. Biol., 826, 89–102.
26.
WakaoS., KurodaY., OguraF., ShigemotoT., and DezawaM. (2012b). Regenerative effects of mesenchymal stem cells: Contribution of Muse cells, a novel pluripotent stem cell type that resides in mesenchymal cells. Cells, 1, 1045–1060.
27.
WakaoS., KitadaM., and DezawaM. (2013). The elite and stochastic model for iPS cell generation: Multilineage-differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells. Cytometry A, 83, 18–26.
28.
WakaoS., AkashiH., KushidaY., and DezawaM. (2014). Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues. Pathol. Int., 64, 1–9.
29.
YamauchiT., KurodaY., MoritaT., ShichinoheH., HoukinK., DezawaM., and KurodaS. (2015). Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One, 10, e0116009.
30.
YoungR.A. (2011). Control of the embryonic stem cell state. Cell, 144, 940–954.
